fluorescein has been researched along with Airflow Obstruction, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dohgu, S; Futagami, K; Kataoka, Y; Koga, M; Takata, F; Tominaga, K; Yamauchi, A | 1 |
| Hodge, S; Reynolds, PN | 1 |
1 trial(s) available for fluorescein and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Low-dose azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophages in chronic obstructive pulmonary disease subjects.
Topics: Adult; Aged; Anti-Bacterial Agents; Apoptosis; Azithromycin; Bronchoalveolar Lavage; Bronchoscopy; Dose-Response Relationship, Drug; Escherichia coli; Female; Fluorescein; Humans; Longitudinal Studies; Macrophages; Macrophages, Alveolar; Male; Middle Aged; Necrosis; Phagocytosis; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2012 |
1 other study(ies) available for fluorescein and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Elevated permeability of the blood-brain barrier in mice intratracheally administered porcine pancreatic elastase.
Topics: Administration, Inhalation; Animals; Blood-Brain Barrier; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Evans Blue; Fluorescein; Leukocyte Count; Mice; Neutrophils; Oxygen; Pancreatic Elastase; Permeability; Pulmonary Disease, Chronic Obstructive; Swine | 2015 |